missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human NLRP3/NALP3 Antibody, R&D Systems™
Mouse Monoclonal Antibody
Marca: R&D Systems MAB67891-SP
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
NLRP3/NALP3 Monoclonal specifically detects NLRP3/NALP3 in Human samples. It is validated for Western Blot.
Especificaciones
| NLRP3/NALP3 | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS. | |
| AGTAVPRL, AII, AII/AVP, Angiotensin/vasopressin receptor AII/AVP-like, AVP, C1orf7, Caterpiller protein 1.1, CIAS1, CLR1.1, Cold autoinflammatory syndrome 1, Cold autoinflammatory syndrome 1 protein, Cryopyrin, Familial cold autoinflammatory syndrome, FCAS, FCU, Leucine-rich repeat-, and PYD-containing protein 3, Muckle-Wells syndrome, MWS, NACHT, NACHT, LRR and PYD containing protein 3, NACHT, LRR and PYD domains-containing protein 3, NALP3, NLR family, pyrin domain containing 3, NLRP3, Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Pyrin Domain Containing 3, PYPAF1, PYRIN-containing APAF1-like protein 1 | |
| E. coli-derived recombinant human NALP-3/NALP3, Met3-Val223, Accession # Q96P20 | |
| 25 μg | |
| Primary | |
| Detects human NALP-3/NALP3 in direct ELISAs. | |
| Human | |
| Purified |
| Western Blot | |
| 447609 | |
| Western Blot 2 ug/mL | |
| Q96P20 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 114548 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution. | |
| IgG2b |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido